908 Devices Inc (MASS)
5.755
+0.08
(+1.50%)
USD |
NASDAQ |
Apr 29, 16:00
5.76
0.00 (0.00%)
After-Hours: 20:00
908 Devices Cash from Financing (Quarterly): 0.095M for Dec. 31, 2023
Cash from Financing (Quarterly) Chart
Historical Cash from Financing (Quarterly) Data
| Date | Value |
|---|---|
| December 31, 2023 | 0.095M |
| September 30, 2023 | -0.248M |
| June 30, 2023 | -0.401M |
| March 31, 2023 | -15.38M |
| December 31, 2022 | 0.411M |
| September 30, 2022 | 0.171M |
| June 30, 2022 | 0.467M |
| March 31, 2022 | 0.13M |
| Date | Value |
|---|---|
| December 31, 2021 | 94.53M |
| September 30, 2021 | 0.483M |
| June 30, 2021 | 0.276M |
| March 31, 2021 | -0.566M |
| December 31, 2020 | 137.18M |
| September 30, 2020 | 0.005M |
| June 30, 2020 | 0.001M |
| March 31, 2020 | 0.003M |
Cash From Financing Definition
Cash flow from financing is a major line item of the statement of cash flows. This metric tracks the movement of cash flows for the overall financing activities of the company. A few examples of financing activities include common stock issuance, total dividends paid, and net debt issuance.
Cash from Financing (Quarterly) Range, Past 5 Years
-15.38M
Minimum
Mar 2023
137.18M
Maximum
Dec 2020
13.57M
Average
0.1125M
Median
Cash from Financing (Quarterly) Benchmarks
| Perspective Therapeutics Inc | 0.352M |
| Retractable Technologies Inc | -0.1364M |
| Xtant Medical Holdings Inc | 0.325M |
| Asensus Surgical Inc | 0.172M |
| Catheter Precision Inc | -0.107M |
Cash from Financing (Quarterly) Related Metrics
| Cash from Operations (Quarterly) | -1.93M |
| Cash from Investing (Quarterly) | 4.636M |
| Free Cash Flow | -27.10M |
| Free Cash Flow Per Share (Quarterly) | -0.0698 |
| Free Cash Flow to Equity (Quarterly) | -2.263M |
| Free Cash Flow to Firm (Quarterly) | -2.263M |
| Free Cash Flow Yield | -14.61% |